New COVID variant XBB.1.16 fuels surge in cases in India and causes conjunctivitis among children
A new COVID variant, XBB.1.16, is causing a surge in pediatric COVID cases in India, with doctors noting an increase in conjunctivitis among children, and reports suggesting already an increase in the US, Singapore, and Australia.
A new COVID variant, XBB.1.16, is causing a surge in pediatric COVID cases in India, with doctors noting an increase in conjunctivitis among children, and reports suggesting already an increase in the US, Singapore, and Australia.
T he World Health Organization (WHO) has alerted the world to a new COVID variant dubbed “Arcturus”. This variant is spreading rapidly and more easily, appearing in 22 countries.
Maria Van Kerkhove, the WHO’s COVID Technical Lead, has described it as “one to watch”.
While the Kraken XBB.1.5 strain has been the dominant variant up to now, the new Arcturus variant is causing concern due to its higher infectivity. However, there is no evidence that this variant leads to more severe illness.
CONTINUE READING...
Enjoy unlimited access now.
To get full access to this article,
simply become a member of EUROPEANS TODAY now.
By doing so, you will be supporting
our independent journalism.
MEMBERSHIP OPTIONS:
£3/month ∙ £5/month ∙ £7/month
You can cancel anytime.
BECOME A MEMBER
Already a member? Sign in here!
BENEFITS OF MEMBERSHIP:
✅ Read exclusive member-only articles
✅ Read our daily review of the UK front pages
✅ Receive every new article by email
✅ Access all our articles
✅ Get Special Discounts with our partners
✅ Join the conversation: Comment our articles
✅ Access our archives
✅ More importantly: Support independent journalism and keep the magazine going
